Jubilant Pharmova (JUBLPHARMA) — Announcement

📢 Key Event
Jubilant Pharmova receives GST show cause notice

💡 Investor Takeaway
The notice poses no expected financial or operational impact as the company will contest it.

Jubilant Pharmova received a GST show cause notice from Mysore tax authorities on August 31, 2026, demanding Rs 87.31 crore in tax, interest and penalty for FY2022-23, which it disputes as legally flawed and plans to contest with documentary evidence.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JUBLPHARMA ✨ Ask AI About This

About Jubilant Pharmova Ltd (JUBLPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹14,469.9 Cr P/E: 40.9 ROE: 5.0% ROCE: 7.4% Div Yield: 0.55%

View full JUBLPHARMA stock details →

📡 Get AI alerts when JUBLPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JUBLPHARMA — Free

💡 Ask AI about this filing

"How does the disputed Rs 87.31 crore compare to Jubilant's FY23 revenue?" "What evidence will Jubilant submit to contest the GST demand?" "Has Jubilant previously faced similar GST disputes with Mysore authorities?"

Ask AI Free →

📊 More JUBLPHARMA filings

See all JUBLPHARMA filings →

🔥 Also filed on 1 September 2026

544083 Shree Marutinandan Tubes Ltd Annual Report SUNPHARMA Sun Pharmaceutical Industries Ltd Announcement SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement FORTIS Fortis Healthcare Ltd Announcement JNPR Juniper Green Energy Ltd Announcement SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JUBLPHARMA files new disclosures

Track JUBLPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JUBLPHARMA — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd